Navigation Links
Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
Date:5/9/2011

ce Sheets(In thousands, except share and par value amounts)March 31,December 31,20112010(Unaudited)AssetsCurrent assets:Cash and cash equivalents

$
39,634$
24,926Investment securities, available-for-sale

36,94667,440Prepaid expenses and other current assets

1,0562,502Total current assets

77,63694,868Property and equipment, net

774894Restricted cash

881881Other assets

107203Total assets

$
79,398$
96,846Liabilities and stockholders' equity Current liabilities:Accounts payable and accrued expenses

$
5,047$
,355Deferred revenue, current portion

3,4293,517Long-term debt, current portion

1,0672,416Total current liabilities

9,54316,288Deferred revenue, less current portion

44,57146,311Other long-term liabilities

428459Commitments and contingenciesStockholders’ equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at March 31, 2011 and December 31, 2010; noshares issued and outstanding at  March 31, 2011 and December 31, 2010--Common stock, $.001 par value, 100,000,000 sharesauthorized at March 31, 2011 and December 31, 2010;48,078,553 and 47,767,313 shares issued and outstanding at March 31, 2011 and December 31, 2010, respectively

4848Additional paid-in capital

355,056352,401Accumulated other comprehensive income (loss)

7(9)Accumulated deficit

(330,255)(318,652)Total stockholders’ equity

24,85633,788Total liabilities and stockholders’ equity

$
79,398$
96,846Orexigen Therapeutics, Inc.Statements of Operations(In thousands, except per share amounts) (Unaudited)Three Months Ended March 31, 20112010Revenues:Collaborative agreement $

857$

-License revenue 97122Total revenues 1,82822Operating expenses:Research and development 6,5677,981General and administrative 6,7596,021Total operating expenses 13,32614,002Loss from operations (11,498)(13,980)Oth
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
2. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
3. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
4. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
5. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
6. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
7. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
8. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
9. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
10. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
11. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Nevro Corp. (NYSE: ... that is providing innovative evidence-based solutions for the ... of the SENZA-RCT results in the Online First ... the American Society of Anesthesiologists. ... that was the first to directly compare spinal ...
(Date:7/28/2015)... Research and Markets ... the "Craniomaxillofacial Implants Market - Global Industry ... - 2022" report to their offering. ... studies the current and future prospects of the ... in the global market due to increasing facial ...
(Date:7/28/2015)... OKLAHOMA CITY , July 28, 2015 /PRNewswire/ ... PDRX) today announced that it has partnered with ... their Infrastructure as a Service (IaaS) product. ... to medical practices across the United States.  Using ... improve disaster recovery and business continuity, ensure regulatory ...
Breaking Medicine Technology:Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2Global Craniomaxillofacial Implants (Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) Market Analysis 2014-2022 2PD-Rx Partners With Dobson Technologies 2
... , ... ... ... ...
... ... ... , ... , , ...
Cached Medicine Technology:DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 2DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 3DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 4DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 5DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 6DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 7DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 8DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 9DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 10DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 11DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 12DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 13DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 14DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results 15Hiroshi Uchida Named President and CEO of Magellan 2Hiroshi Uchida Named President and CEO of Magellan 3Hiroshi Uchida Named President and CEO of Magellan 4Hiroshi Uchida Named President and CEO of Magellan 5
(Date:7/29/2015)... ... 29, 2015 , ... Hernia repairs have always been common and routine surgical ... the National Center for Health Statistics indicates that more than five million Americans ... annually. While the only effective treatment for a hernia is surgery, only about 750,000 ...
(Date:7/29/2015)... ... 29, 2015 , ... ITW Dynatec, along with Zip-Pak and ... is responsible for driving growth and innovation across ITW Dynatec’s worldwide customer base ... an effective leader within the ITW community speaks for itself. We are delighted ...
(Date:7/28/2015)... ... July 29, 2015 , ... ... lawyers and other A-Listers, has evolved into a world class millionaires club, according ... strives to match successful and attractive people seeking real, meaningful and mutually beneficial ...
(Date:7/28/2015)... ... July 29, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. ... the nation's leading networking organization exclusively for professional women, boasting more than 700,000 ...
(Date:7/28/2015)... ... , ... Every July, since 2007, about 25 pediatric pulmonary hypertension (PH) patients ... television. They go to summer camp. , PH is incurable and life threatening, as ... pushes hard to get blood through arteries in the lungs narrowed by the disease. ...
Breaking Medicine News(10 mins):Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 2Health News:National Statistics Reflect NCMA General Surgery Physicians Findings: Hernia Patients Who Seek Treatment Promptly are More Likely to Enjoy a Quick Recovery 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:Meet a Millionaire Announces It’s Not a Sugar Daddy Site, It’s a True Millionaires Club 2Health News:National Association of Professional Women Inducts Susan Bentley, Owner of Women's Wellness Options, Into its VIP Woman of the Year Circle 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
... more than 15 percent in 3 years, researchers say, , , ... children and teens taking drugs to lower blood pressure and ... new study. , The study is one of several reports ... Archives of Pediatrics & Adolescent Medicine . , In the ...
... 6 Michael Mack, M.D., a surgeon on the ... and medical director of cardiovascular surgery for Baylor Health ... of Thoracic Surgeons. In this role, Mack will provide ... allied health professionals worldwide who are members of the ...
... recognize customers and partners improving the quality of ... Microsoft Health Users Group (Microsoft HUG) and Microsoft ... annual Microsoft HUG 2009 Innovation Awards. For more ... to healthcare organizations, software vendors and systems integrators ...
... through Education and Research InitiativesNEW YORK, April 6 ... a leadership contributor with the National Thoroughbred Racing ... aim is to ensure the health and safety ... program are addressed in a manner that will ...
... of Chronic Disease and Promote Reform Needed to Address Health ... National and state health care experts, civic leaders, and ... for comprehensive health and economic reform to address the growing ... nation. , , Who: State ...
... breast or ovarian disease , , MONDAY, April 6 (HealthDay ... in federal grants for two studies into whether exercise ... U.S. National Cancer Institute funding will go to test ... can improve survival rates as well as cancer patients, ...
Cached Medicine News:Health News:More U.S. Kids Taking Diabetes, Blood Pressure Drugs 2Health News:More U.S. Kids Taking Diabetes, Blood Pressure Drugs 3Health News:More U.S. Kids Taking Diabetes, Blood Pressure Drugs 4Health News:Surgeon Named President-Elect of National Organization 2Health News:Surgeon Named President-Elect of National Organization 3Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 2Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 3Health News:Microsoft and Microsoft Health Users Group Announce Winners of Microsoft HUG 2009 Innovation Awards 4Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 2Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 3Health News:Bipartisan CT Coalition Forms to Fight Spiraling Health Care Costs 2Health News:Yale Plans Closer Look at Exercise and Cancer 2
... offers a range of standard, enhanced ... delivers therapy to meet the needs ... in commercial and clinical effectiveness and ... the SleepStyle 200 series is the ...
... The ResMed S6 Lightweight II CPAP ... microprocessor-controlled motor that maintains consistent pressure. ... and adjusting the settings easy, and ... and make adjustments is simple. This ...
The S8 Escape is the economy model of ResMeds S8 series. The S8 Escape is ideal for patients who want the convenience and portability of the S8 models but do not require the added comfort features of...
The S7 Elite is the premium device in ResMeds award-winning S7 series. All S7 devices include an option of integrated humidification....
Medicine Products: